Bioforce Nanosciences Holdings, Inc. (BFNH) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

Bioforce Nanosciences Holdings, Inc.

CIK: 1370431 Ticker: BFNH
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2018
Oct. 24, 2018
Document And Entity Information  
Entity Central Index Key0001310488 
Document Type10-Q 
Document Period End DateSep. 30, 2018 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Common Stock, Shares Outstanding 76,300,163
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2018 

View differences made from one quarter to another to evaluate Bioforce Nanosciences Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bioforce Nanosciences Holdings, Inc..


Assess how Bioforce Nanosciences Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bioforce Nanosciences Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Bioforce Nanosciences Holdings, Inc. provided additional information to their SEC Filing as exhibits

Ticker: BFNH
CIK: 1310488
Form Type: 10-Q Quarterly Report
Accession Number: 0001091818-18-000190
Submitted to the SEC: Wed Oct 24 2018 4:02:16 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Sunday, September 30, 2018
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: